Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 InhibitorsMohamed Shanavas, Vikas Gupta, Donal P. McLornan et al.|Biology of Blood and Marrow Transplantation|2015Cited by 142
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesisTingdong Yan, Shang Li, Wen Fong Ooi et al.|Nature Communications|2018Cited by 52